Home > News > pSivida to gets approval to test cancer cure on humans
April 26th, 2004
pSivida to gets approval to test cancer cure on humans
Abstract:
Global nanotechnology company pSivida Limited (PSD) today announced that its Singapore subsidiary has obtained all the necessary approvals to commence Phase IIa human clinical trials for its lead brachytherapy product, BrachySilT. The 12 week trial is scheduled to commence in May and will be conducted by Singapore’s National Cancer Centre (“NCC”).
Source:
egoli
Bookmark:
| Related News Press |
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||